120 related articles for article (PubMed ID: 20447573)
1. Prognostic significance of acute kidney injury after reperfused ST-elevation myocardial infarction: synergistic acceleration of renal dysfunction and left ventricular remodeling.
Anzai A; Anzai T; Naito K; Kaneko H; Mano Y; Jo Y; Nagatomo Y; Maekawa Y; Kawamura A; Yoshikawa T; Ogawa S
J Card Fail; 2010 May; 16(5):381-9. PubMed ID: 20447573
[TBL] [Abstract][Full Text] [Related]
2. [Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation acute myocardial infarction managed with primary percutaneous coronary intervention].
Parenica J; Kala P; Jarkovský J; Poloczek M; Toman O; Goldbergová MP; Manousek J; Prymusová K; Kubková L; Tesák M; Elbl L; Cermáková Z; Spinar J
Vnitr Lek; 2011 Jan; 57(1):43-51. PubMed ID: 21351662
[TBL] [Abstract][Full Text] [Related]
3. Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling.
Naito K; Anzai T; Yoshikawa T; Maekawa Y; Sugano Y; Kohno T; Mahara K; Okabe T; Asakura Y; Ogawa S
J Card Fail; 2007 Feb; 13(1):25-33. PubMed ID: 17339000
[TBL] [Abstract][Full Text] [Related]
4. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling.
Naito K; Anzai T; Yoshikawa T; Anzai A; Kaneko H; Kohno T; Takahashi T; Kawamura A; Ogawa S
J Card Fail; 2008 Dec; 14(10):831-8. PubMed ID: 19041046
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
[TBL] [Abstract][Full Text] [Related]
6. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission.
Marenzi G; Assanelli E; Campodonico J; De Metrio M; Lauri G; Marana I; Moltrasio M; Rubino M; Veglia F; Montorsi P; Bartorelli AL
Crit Care Med; 2010 Feb; 38(2):438-44. PubMed ID: 19789449
[TBL] [Abstract][Full Text] [Related]
8. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of left ventricular dyssynchrony early after non-ST elevation myocardial infarction without congestive heart failure.
Ng AC; Tran da T; Allman C; Vidaic J; Leung DY
Eur Heart J; 2010 Feb; 31(3):298-308. PubMed ID: 19933227
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
11. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of left ventricular enlargement and long-term prognosis after reperfused acute myocardial infarction.
Lipiecki J; Durel N; Ernande L; Monzy S; Muliez A; Ponsonnaille J
Arch Cardiovasc Dis; 2009; 102(8-9):599-605. PubMed ID: 19786263
[TBL] [Abstract][Full Text] [Related]
13. ST-segment depression in lead aVR predicts predischarge left ventricular dysfunction in patients with reperfused anterior acute myocardial infarction with anterolateral ST-segment elevation.
Kosuge M; Kimura K; Ishikawa T; Endo T; Hongo Y; Shigemasa T; Iwasawa Y; Tochikubo O; Umemura S
Am Heart J; 2001 Jul; 142(1):51-7. PubMed ID: 11431656
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction.
Zhang Y; Wang L
Med Hypotheses; 2006; 67(5):1076-8. PubMed ID: 16697117
[TBL] [Abstract][Full Text] [Related]
15. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction.
Goldberg A; Hammerman H; Petcherski S; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Markiewicz W; Aronson D
Am Heart J; 2005 Aug; 150(2):330-7. PubMed ID: 16086939
[TBL] [Abstract][Full Text] [Related]
16. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
[TBL] [Abstract][Full Text] [Related]
17. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction.
Kaneko H; Anzai T; Naito K; Kohno T; Maekawa Y; Takahashi T; Kawamura A; Yoshikawa T; Ogawa S
J Card Fail; 2009 Nov; 15(9):775-81. PubMed ID: 19879464
[TBL] [Abstract][Full Text] [Related]
18. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
[TBL] [Abstract][Full Text] [Related]
19. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
